JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock
-
Concert Pharmaceuticals Announces Completion of Public Offering
-
CounterTack Named to JMP Securities' Fast 50 List of Hottest Privately Held Security and Networking Firms
-
Ivalua Appoints Kevin Brooks as Chief Marketing Officer
-
Blueprint Medicines Files Registration Statement for Proposed Initial Public Offering
-
Netskope Named to JMP Securities Fast 50 List of Hottest Privately Held Security and Networking Companies
-
Blueprint Medicines (BPMC) Files $100M IPO
-
La Quinta Announces Secondary Offering of 17,500,000 Shares of Common Stock
-
Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Private Company Conference Series
-
RedSeal Named to JMP Securities' Fast 50 List of Hottest Privately Held Security and Networking Firms
-
SteadyMed (STDY) IPO Opens Lower
-
Tekmira Announces Pricing of Underwritten Public Offering of Common Shares
-
SteadyMed (STDY) IPO Prices at $8.50/Share, Well Below Expected Range
-
SteadyMed Announces Pricing of Initial Public Offering
-
Apigee Files Registration Statement for Proposed Initial Public Offering
-
Apigee Corporation (APIC) Files for $86.25M IPO
-
Mimosa Networks Named to JMP Securities’ Inaugural Fast 50 List
-
Kadmon Corporation to Present at Two Upcoming Investor Conferences
-
Concert Pharma (CNCE) Prices 3.3M Common Stock Offering at $15.15/Share
-
Concert Pharmaceuticals Announces Pricing of Public Offering
-
GoDaddy Sees IPO Price of $17 - $19/Share; Values Company ~3B
-
Retrophin (RTRX) Prices 6.84M Common Offering at $19/Share
-
Retrophin Prices Public Offering of 6,840,000 Shares of Common Stock
-
Esperion Therapeutics (ESPR) Prices 1.75M Common Offering at $100/Share
-
Esperion Therapeutics Prices Public Offering of Common Stock
-
Concert Pharma (CNCE) Plans Common Stock Offering
-
Tekmira Pharma (TKMR) to Offer 6M Common Shares
-
Concert Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Tekmira Announces Proposed Public Offering of Common Shares
-
Tekmira Announces Proposed Public Offering of Common Shares
-
Summit Therapeutics Announces Exercise of Over-Allotment Option
-
JMP Securities Engaged by Procida's 100 Mile Fund
-
Tekmira Pharma (TKMR) Appoints Three New Executives
-
Epizyme (EPZM) 6M Offering Prices at $20.75/Share
-
Tekmira Strengthens Senior Leadership Team With Key Executive Appointments in Corporate Affairs, Chemistry and Biology
-
Tekmira Strengthens Senior Leadership Team With Key Executive Appointments in Corporate Affairs, Chemistry and Biology
-
Flex Pharma Reports Year End 2014 Financial Results
-
JMP Securities Upgrades Charles Schwab Corp. (SCHW) to Market Outperform
-
Form 4 Harvest Capital Credit For: Mar 12 Filed by: JMP SECURITIES LLC
-
Form 4 Harvest Capital Credit For: Mar 12 Filed by: JMP SECURITIES LLC
-
Epizyme (EPZM) to Offer 4.75M Common Shares
-
Horizon Pharma plc Closes Offering of $400 Million of 2.50% Exchangeable Senior Notes, Including Exercise in Full of Option to Purchase Additional Notes
-
Marcus & Millichap (MMI) Lower After Pricing 4M Common Offering at $33.50/Share
-
Marcus & Millichap, Inc. Prices Secondary Offering of 4.0 Million Shares
-
Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
-
Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
-
BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares
-
Summit Therapeutics Announces Closing of Its U.S. Initial Public Offering
-
SteadyMed Ltd. Launches Initial Public Offering
-
GoPro (GPRO) Weakness Related to Apple Event - Analyst

